Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 144.72

+0.5%

11:02 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (770)	7/17/2001 3:06:16 PM
From: Icebrg	Read Replies (1) of 1834

Wilder Just a small note on the timeframe. As I understood the answer to Dr. Tracy's question, they expect to have all trials completed for the standard formulation by the middle of 2003 and to file towards the end of that year. Not that it matters very much at present. It is still relatively far out. Ice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next